Description
____________Career Highlights____________ Entrusted by senior management with creating the metrics for the TSDV (risk base monitoring) model and centralized monitoring model for Alcon, Research Ltd. Phase I - Phase 3 trials, netting $12 million in cost savings. Played a key role in improving merge eClinical solutions client base from 4 to 10 major sponsors within an 8-month period, which proved instrumental in increasing revenue from $750,000 to $1.2 million per month. Manage all contract service budgets at AAIPharma, Inc that generated a profit increase of 20-25%. Additionally, achieved P&Ls of 80% at AAIPharma, Inc. against target of 60% for both U.S. and International Groups. Demonstrated track record of maintaining controllable indirect expenses at plan of $41.7 million for Abbott Labs.
Accomplishments
Highlights:
